Drug Type Small molecule drug |
Synonyms |
Target |
Action inhibitors |
Mechanism BRD4 inhibitors(Bromodomain-containing protein 4 inhibitors), CDK6 inhibitors(Cyclin-dependent kinase 6 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Molecular FormulaC37H39N7O5 |
InChIKeyGCDVHXYXNPHYTC-UHFFFAOYSA-N |
CAS Registry3036645-03-8 |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Triple Negative Breast Cancer | Preclinical | China | 22 Nov 2024 |